Valuation: Imexpharm Corporation

Market Cap 5,498B 209M 181M 170M 154M 291M 19.98B 302M 2.01B 786M 9.88B 786M 770M 34.14B P/E 2026 *
15.5x
P/E 2027 * 14.3x
Enterprise Value 5,498B 209M 181M 170M 154M 291M 19.98B 302M 2.01B 786M 9.88B 786M 770M 34.14B EV / Sales 2026 *
2.07x
EV / Sales 2027 * 1.91x
Free-Float
6.42%
Yield 2026 *
2.8%
Yield 2027 * 2.8%
1 day+2.00%
1 week-0.83%
Current month-13.35%
1 month-15.10%
3 months-24.84%
6 months-33.64%
Current year-32.00%
1 week 32,650
Extreme 32650
36,000
1 month 32,650
Extreme 32650
43,150
Current year 32,650
Extreme 32650
57,000
1 year 32,650
Extreme 32650
57,000
3 years 23,681.82
Extreme 23681.8182
57,000
5 years 18,831.17
Extreme 18831.1688
57,000
10 years 12,793.53
Extreme 12793.5306
57,000
Manager TitleAgeSince
Chief Executive Officer 74 2001-07-31
Director of Finance/CFO 52 2024-01-17
Chief Operating Officer 47 -
Director TitleAgeSince
Chairman 74 1983-12-31
Director/Board Member 50 2018-04-27
Director/Board Member - 2020-05-29
Date Insider Type Main position Quantity % Market Cap.
9/26/22 Buy

Chief Executive Officer

140,000 0.2100%
7/20/22 Sell

Chief Executive Officer

100,000 0.1500%
4/1/22 Fiscal year

Chairman

50,000 0.0750%
Change 5-day change 1-year change 3-year change Capi.($)
+2.00%-0.83%-31.21%+15.99% 205M
-0.87%+2.94%+49.73%+163.92% 1,089B
-0.45%+5.95%+59.75%+52.18% 643B
+0.04%+2.81%+39.67%+74.54% 465B
-1.69%+8.36%+38.80%+34.26% 359B
-0.51%+3.35%+39.00%+43.76% 303B
+1.50%+5.14%+21.72%+18.77% 267B
+0.79%+4.32%-25.07%-36.02% 226B
-1.39%+5.84%+28.66%+64.00% 212B
-1.18%+1.88%+17.43%+72.69% 167B
Average -0.36%+4.77%+23.85%+50.41% 373.13B
Weighted average by Cap. -0.68%+5.14%+39.09%+79.00%

Financials

2026 *2027 *
Net sales 2,659B 101M 87.75M 82.43M 74.45M 141M 9.66B 146M 973M 380M 4.78B 380M 372M 16.51B 2,881B 109M 95.07M 89.31M 80.67M 153M 10.47B 158M 1.05B 412M 5.18B 412M 403M 17.89B
Net income 394B 14.97M 13M 12.21M 11.03M 20.88M 1.43B 21.67M 144M 56.34M 708M 56.34M 55.16M 2.45B 428B 16.26M 14.12M 13.27M 11.98M 22.68M 1.56B 23.54M 157M 61.2M 769M 61.2M 59.92M 2.66B
Net Debt - -
Logo Imexpharm Corporation
Imexpharm Corporation is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. It is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.
Employees
1,438
Date Price Change Volume
26-07-29 ₫35,700.00 +2.00% 7,894
26-07-28 ₫35,000.00 0.00% 8,610
26-07-27 ₫35,000.00 0.00% 12,818
26-07-24 ₫35,000.00 0.00% 23,506
26-07-23 ₫35,000.00 -2.23% 13,905
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
35,700.00VND
Average target price
56,000.00VND
Spread / Average Target
+56.86%

Annual profits - Rate of surprise